Collagen triple helix repeat containing-1 inhibits transforming growth factor-β1-induced collagen type I expression in keloid

British Journal of Dermatology

Volumn 164, Issue 5, 2011, Pages 1030-1036

  Li, J ^a   Cao, J ^a   Li, M ^a   Yu, Y ^a   Yang, Y ^a   Xiao, X ^a   Wu, Z ^b   Wang, L ^a,c   Tu, Y ^a   Chen, H ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CTHRC 1 GENE; FIBROBLAST; GENE; GENE CONTROL; GENE EXPRESSION; KELOID; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIPLE HELIX;

BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; KELOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79955370589     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10215.x     Document Type: Article

References (34)

1. Mutalik S,. Treatment of keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol 2005; 71: 3-8. (Pubitemid 40348224)
2. Poochareon VN, Berman B,. New therapies for the management of keloids. J Craniofac Surg 2003; 14: 654-7.
3. Niessen FB, Spauwen PH, Schalkwijk J, et al. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999; 104: 1435-58. (Pubitemid 29466295)
4. Derynck R, Zhang YE,. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-84. (Pubitemid 37280136)
5. Tuan TL, Nichter LS,. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998; 4: 19-24. (Pubitemid 28124795)
6. Border WA, Noble NA,. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 1286-92. (Pubitemid 24333194)
7. Younai S, Nichter LS, Wellisz T, et al. Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts. Ann Plast Surg 1994; 33: 148-51.
8. Wang R, Ghahary A, Shen Q, et al. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen 2000; 8: 128-37. (Pubitemid 30238326)
9. Hanasono MM, Kita M, Mikulec AA, et al. Autocrine growth factor production by fetal, keloid, and normal dermal fibroblasts. Arch Facial Plast Surg 2003; 5: 26-30.
10. Van Obberghen-Schilling E, Roche NS, Flanders KC, et al. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem 1988; 263: 7741-6.
11. Tomasek JJ, Gabbiani G, Hinz B, et al. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3: 349-63. (Pubitemid 34619269)
12. Pyagay P, Heroult M, Wang Q, et al. Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ Res 2005; 96: 261-8. (Pubitemid 40209374)
13. LeClair RJ, Durmus T, Wang Q, et al. Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation. Circ Res 2007; 100: 826-33. (Pubitemid 46555687)
14. Coussens LM, Werb Z,. Inflammation and cancer. Nature 2002; 420: 860-7. (Pubitemid 36019639)
15. Beachy PA, Karhadkar SS, Berman DM,. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432: 324-31. (Pubitemid 39551660)
16. Turashvili G, Bouchal J, Baumforth K, et al. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 2007; 7: 55.
17. Tang L, Dai DL, Su M, et al. Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin Cancer Res 2006; 12: 3716-22. (Pubitemid 44000252)
18. Tano K, Mizuno R, Okada T, et al. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 2010; 584: 4575-80.
19. Wang L, Xiang YN, Zhang YH, et al. Collagen triple helix repeat containing-1 in the differential diagnosis of dermatofibrosarcoma protuberans and dermatofibroma. Br J Dermatol 2011; 164: 135-40.
20. Durmus T, LeClair RJ, Park KS, et al. Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1). Gene Expr Patterns 2006; 6: 935-40. (Pubitemid 44309445)
21. LeClair R, Lindner V,. The role of collagen triple helix repeat containing 1 in injured arteries, collagen expression, and transforming growth factor beta signaling. Trends Cardiovasc Med 2007; 17: 202-5. (Pubitemid 47089010)
22. Zhang GY, Yi CG, Li X, et al. Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid. Arch Dermatol Res 2008; 300: 177-84.
23. Dubey RK, Gillespie DG, Jackson EK,. Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: role of A2B receptors. Hypertension 1998; 31: 943-8. (Pubitemid 28185572)
24. Murray JC,. Keloids and hypertrophic scars. Clin Dermatol 1994; 12: 27-37. (Pubitemid 24050735)
25. Williams RL, Armstrong DG,. Wound healing. New modalities for a new millennium. Clin Podiatr Med Surg 1998; 15: 117-28. (Pubitemid 28072934)
26. Bettinger DA, Yager DR, Diegelmann RF, et al. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996; 98: 827-33. (Pubitemid 26322164)
27. Lee TY, Chin GS, Kim WJ, et al. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 1999; 43: 179-84. (Pubitemid 29380019)
28. Falanga V,. Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol 1993; 100: 721-5. (Pubitemid 23128373)
29. Ghahary A, Tredget EE, Bahar MA, et al. Cell proliferating effect of latent transforming growth factor-beta1 is cell membrane dependent. Wound Repair Regen 2002; 10: 328-35. (Pubitemid 35315682)
30. Clark RA, McCoy GA, Folkvord JM, et al. TGF-beta 1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: a fibronectin matrix-dependent event. J Cell Physiol 1997; 170: 69-80. (Pubitemid 27046524)
31. Campaner AB, Ferreira LM, Gragnani A, et al. Upregulation of TGF-beta1 expression may be necessary but is not sufficient for excessive scarring. J Invest Dermatol 2006; 126: 1168-76.
32. Leclair RJ, Wang Q, Benson MA, et al. Intracellular localization of Cthrc1 characterizes differentiated smooth muscle. Arterioscler Thromb Vasc Biol 2008; 28: 1332-8.
33. Ramos ML, Gragnani A, Ferreira LM,. Is there an ideal animal model to study hypertrophic scarring? J Burn Care Res 2008; 29: 363-8. (Pubitemid 351498833)
34. Yang DY, Li SR, Wu JL, et al. Establishment of a hypertrophic scar model by transplanting full-thickness human skin grafts onto the backs of nude mice. Plast Reconstr Surg 2007; 119: 104-9; discussion 10-11. (Pubitemid 46360252)